Rising bill for new drugs threatens to overwhelm patients, employers

Putting a strain on mutual cashflow
The Seattle Times

SEATTLE --Sally Garcia, a 53-year-old lawyer disabled by multiple sclerosis, was torn.

A new-generation medication, Copaxone, was really working for her. After two decades of being in and out of hospitals, Garcia was taking steps to work again.

Her wallet, though, was in severe distress. Under her Medicare prescription plan, Garcia's share of the expensive drug was $330 per month. All together, medications were taking a third of her disability payments -- her only income -- and she couldn't swing it.

» Read More